0 rating

Report from the 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2010)

Cornelia Lass-Flörl, MD, PhD1, and Joanna Lumb, BSc2

Clinicians and scientists attending the 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria on 10–13 April 2010 heard updates on the changing epidemiology of invasive fungal infections (IFI) and the continuing challenge of antifungal drug resistance. There were also presentations highlighting new developments in the prophylaxis and treatment of serious fungal infections, and discussion on whether pre-emptive therapy will succeed in targeting antifungal treatment to patients who most need it.

Return to top

LATEST ARTICLES